Corporate Profile

Adverum is a clinical-stage gene therapy company targeting unmet medical need in ocular and rare diseases. We develop gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein.

Learn More

Recent News

Latest Financial Reports

NASDAQ: ADVM

Upcoming Events

There are currently no events to display.
View More